
A NOVEL VARIANT IN THE LIPA GENE
ASSOCIATED WITH DISTINCT PHENOTYPE Sarajlija A.1,6, Armengol L.2, Maver A.3, Kitic I.4,6, Prokic D.4,6, Cehic M.1, Djuricic M.S.5,7, Peterlin B.3 *Corresponding Author: Adrijan Sarajlija, MD, PhD, Mother and Child Health Care Institute of Serbia
“Dr. Vukan Cupic”, School of Medicine, University of Belgrade, Radoja Dakica 6-8, Belgrade, 11070,
Serbia, Tel: +381113108287, E-mail: adrijans2004@yahoo.com page: 8
|
REFERENCES
1. Ameis D, Merkel M, Eckerskorn C, Greten H. Purification,
characterization and molecular cloning of
human hepatic lysosomal acid lipase. Eur J Biochem.
1994; 219(3): 905-14.
2. Bernstein DL, Hülkova H, Bialer MG, Desnick RJ.
Cholesteryl ester storage disease: review of the findings
in 135 reported patients with an underdiagnosed
disease. J Hepatol. 2013; 58(6): 1230-43.
3. Aslanidis C, Ries S, Fehringer P, Büchler C, Klima
H, Schmitz G. Genetic and biochemical evidence
that CESD and Wolman disease are distinguished
by residual lysosomal acid lipase activity. Genomics.
1996; 33(1) :85-93.
4. Wilson DP, Patni N. Lysosomal Acid Lipase Deficiency.
[Updated 2020 Jan 18]. In: Feingold KR,
Anawalt B, Boyce A, et al., editors. Endotext [Internet].
South Dartmouth (MA): MDText.com, Inc.;
2000-. Available from: https://www.ncbi.nlm.nih.
gov/books/NBK395569/
5. Scott SA, Liu B, Nazarenko I, Martis S, Kozlitina
J, Yang Y et al. Frequency of the cholesteryl ester
storage disease common LIPA E8SJM mutation
(c.894G>A) in various racial and ethnic groups.
Hepatology. 2013; 58(3): 958-65.
6. Cappuccio G, Donti TR, Hubert L, Sun Q, Elsea SH.
Opening a window on lysosomal acid lipase deficiency:
Biochemical, molecular, and epidemiological
insights. J Inherit Metab Dis. 2019; 42(3): 509-18.
7. Pisciotta L, Tozzi G, Travaglini L, Taurisano R, Lucchi
T, Indolfi G et al. Molecular and clinical characterization
of a series of patients with childhood-onset
lysosomal acid lipase deficiency. Retrospective investigations,
follow-up and detection of two novel
LIPA pathogenic variants. Atherosclerosis. 2017; 265:
124-32.
8. Zimetti F, Favari E, Cagliero P, Adorni MP, Ronda N,
Bonardi R et al. Cholesterol trafficking-related serum
lipoprotein functions in children with cholesteryl ester
storage disease. Atherosclerosis [Internet]. 2015;
242(2): 443-9.
9. Pericleous M, Kelly C, Wang T, Livingstone C, Ala A.
Wolman’s disease and cholesteryl ester storage disorder:
the phenotypic spectrum of lysosomal acid lipase
deficiency. Lancet Gastroenterol Hepatol. 2017; 2(9):
670-9.
10. Hůlková H, Elleder M. Distinctive histopathological
features that support a diagnosis of cholesterol ester
storage disease in liver biopsy specimens. Histopathology.
2012; 60(7): 1107-13.
11. Thompson RJ, Portmann BC, Roberts EA. Genetic
and metabolic liver disease. In: Burt AD, Portmann
BC, Ferrell LD, editors. MacSween’s pathology of the
liver (6th edition). Edinburgh: Churchil Livingstone
Elsevier, 2012: 157-259
12. vom Dahl S, Harzer K, Rolfs A, Albrecht B, Niederau
C, Vogt C, van Weely S, Aerts J, Müller G, Häussinger
D. Hepatosplenomegalic lipidosis: what unless Gaucher?
Adult cholesteryl ester storage disease (CESD)
with anemia, mesenteric lipodystrophy, increased
plasma chitotriosidase activity and a homozygous
lysosomal acid lipase -1 exon 8 splice junction mutation.
J Hepatol. 1999; 31(4): 741-6.
13. Boenzi S, Deodato F, Taurisano R, Goffredo BM,
Rizzo C, Dionisi-Vici C. Evaluation of plasma
cholestane-3β,5α,6β-triol and 7-ketocholesterol in
inherited disorders related to cholesterol metabolism.
J Lipid Res. 2016; 57(3): 361-7.
14. Su K, Donaldson E, Sharma R. Novel treatment options
for lysosomal acid lipase deficiency: critical appraisal
of sebelipase alfa. Appl Clin Genet. 2016; 9: 157-67.
15. Pastores GM, Hughes DA. Lysosomal Acid Lipase
Deficiency: Therapeutic Options. Drug Des Devel
Ther. 2020; 14: 591-601.
16. Carter A, Brackley SM, Gao J, Mann JP. The global
prevalence and genetic spectrum of lysosomal acid
lipase deficiency: A rare condition that mimics
NAFLD. J Hepatol. 2019; 70(1): 142-50.
17. Del Angel G, Hutchinson AT, Jain NK, Forbes CD,
Reynders J. Large-scale functional LIPA variant characterization
to improve birth prevalence estimates of
lysosomal acid lipase deficiency. Hum Mutat. 2019;
40(11): 2007-20.
18. Zhang B, Porto AF. Cholesteryl ester storage disease:
protean presentations of lysosomal acid lipase deficiency.
J Pediatr Gastroenterol Nutr. 2013; 56(6): 682-5.
19. Ruiz-Andrés C, Sellés E, Arias A, Gort L; Spanish
LAL Deficiency Working Group. Lysosomal Acid
Lipase Deficiency in 23 Spanish Patients: High Frequency
of the Novel c.966+2T>G Mutation in Wolman
Disease. JIMD Rep. 2017; 37: 7-12.
20. Hoffman EP, Barr ML, Giovanni MA, Murray MF.
Lysosomal Acid Lipase Deficiency. 2015 Jul 30 [Updated
2016 Sep 1]. In: Adam MP, Ardinger HH, Pagon
RA, et al., editors. GeneReviews® [Internet]. Seattle
(WA): University of Washington, Seattle; 1993-2021.
Available from: https://www.ncbi.nlm.nih.gov/books/
NBK305870/
21. Pullinger CR, Stock EO, Movsesyan I, Malloy MJ,
Frost PH, Tripuraneni R et al. Identification and metabolic
profiling of patients with lysosomal acid lipase
deficiency. J Clin Lipidol. 2015; 9(5): 716-26.e1.
22. Aerts JM, Hollak CE, van Breemen M, Maas M,
Groener JE, Boot RG. Identification and use of biomarkers
in Gaucher disease and other lysosomal storage
diseases. Acta Paediatr Suppl. 2005; 94(447):
43-6; discussion 37-8.
23. Zlatkovic M, Stankovic I, Prokic D, Plamenac P.
Patohistoloska dijagnostika bolesti nagomilavanja
estra holesterola [Histopathologic diagnosis of cholesterol
ester storage disease]. Srp Arh Celok Lek.
2001; 129(7-8): 207-10
24. Fasano T, Pisciotta L, Bocchi L, Guardamagna O,
Assandro P, Rabacchi C et al. Lysosomal lipase deficiency:
molecular characterization of eleven patients
with Wolman or cholesteryl ester storage disease. Mol
Genet Metab. 2012; 105(3): 450-6.
25. Arterburn JN, Lee WM, Wood RP, Shaw BW, Markin
RS. Orthotopic liver transplantation for cholesteryl
ester storage disease. J Clin Gastroenterol. 1991;
13(4): 482-5.
26. Andrade J, Waters PJ, Singh RS, Levin A, Toh BC,
Vallance HD et al. Screening for Fabry disease in
patients with chronic kidney disease: limitations of
plasma alpha-galactosidase assay as a screening test.
Clin J Am Soc Nephrol. 2008; 3(1): 139-45.
27. Verma J, Thomas DC, Kasper DC, Sharma S, Puri
RD, Bijarnia-Mahay S et al. Inherited Metabolic Disorders:
Efficacy of Enzyme Assays on Dried Blood
Spots for the Diagnosis of Lysosomal Storage Disorders.
JIMD Rep. 2017; 31: 15-27.
28. Masi S, Chennamaneni N, Turecek F, Scott CR, Gelb
MH. Specific Substrate for the Assay of Lysosomal
Acid Lipase. Clin Chem. 2018; 64(4): 690-6.
29. Lukacs Z, Barr M, Hamilton J. Best practice in the
measurement and interpretation of lysosomal acid
lipase in dried blood spots using the inhibitor Lalistat
2. Clin Chim Acta. 2017;471:201-5.
30. Monserrat L, Gimeno-Blanes JR, Marín F, Hermida-
Prieto M, García-Honrubia A, Pérez I et al. Prevalence
of Fabry disease in a cohort of 508 unrelated
patients with hypertrophic cardiomyopathy. J Am
Coll Cardiol. 2007; 50(25): 2399-403.
31. Vijay S, Brassier A, Ghosh A, Fecarotta S, Abel F,
Marulkar S et al. Long-term survival with sebelipase
alfa enzyme replacement therapy in infants with rapidly
progressive lysosomal acid lipase deficiency:
final results from 2 open-label studies. Orphanet J
Rare Dis. 2021; 16(1): 13.
32. Mashima R, Okuyama T, Ohira M. Biomarkers for
Lysosomal Storage Disorders with an Emphasis on
Mass Spectrometry. Int J Mol Sci. 2020; 21(8): 2704.
33. Clark WT, Yu GK, Aoyagi-Scharber M, LeBowitz JH.
Utilizing ExAC to assess the hidden contribution of
variants of unknown significance to Sanfilippo Type
B incidence. PLoS One. 2018; 13(7): e0200008.
34. Reiner Ž, Guardamagna O, Nair D, Soran H, Hovingh
K, Bertolini S et al. Lysosomal acid lipase deficiency-
-an under-recognized cause of dyslipidemia and liver
dysfunction. Atherosclerosis. 2014; 235(1): 21-30.
35. Guénard F, Houde A, Bouchard L, Tchernof A, Deshaies
Y, Biron S et al. Association of LIPA gene
polymorphisms with obesity-related metabolic complications
among severely obese patients. Obesity
(Silver Spring). 2012; 20(10): 2075-82.
36. Stenson PD, Mort M, Ball EV, Evans K, Hayden M,
Heywood S et al. The Human Gene Mutation Database:
towards a comprehensive repository of inherited
mutation data for medical research, genetic diagnosis
and next-generation sequencing studies. Hum Genet.
2017; 136(6): 665-77.
37. Vinje T, Laerdahl JK, Bjune K, Leren TP, Strøm TB.
Characterization of the mechanisms by which missense
mutations in the lysosomal acid lipase gene
disrupt enzymatic activity. Hum Mol Genet. 2019;
28(18): 3043-52.
38. Oetjen S, Kuhl D, Hermey G. Revisiting the neuronal
localization and trafficking of CLN3 in juvenile
neuronal ceroid lipofuscinosis. J Neurochem. 2016;
139(3): 456-70.
39. Björses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen
J, Ellonen P et al. Mutations in the AIRE gene:
effects on subcellular location and transactivation
function of the autoimmune polyendocrinopathycandidiasis-
ectodermal dystrophy protein. Am J Hum
Genet. 2000; 66(2): 378-92.
|
|
|
|



 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|